{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:43:55Z","timestamp":1795095835321,"version":"4.10.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regional Innovation and Development Joint Fund of National Natural Science Foundation of China","award":["No.U23A20478"],"award-info":[{"award-number":["No.U23A20478"]}]},{"name":"Regional Innovation and Development Joint Fund of National Natural Science Foundation of China","award":["No.U22A20345"],"award-info":[{"award-number":["No.U22A20345"]}]},{"name":"the National Science Foundation for Young Scientists of China","award":["82202267"],"award-info":[{"award-number":["82202267"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0531100, 2024ZD0531101"],"award-info":[{"award-number":["2024ZD0531100, 2024ZD0531101"]}]},{"name":"Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application","award":["No. 2022B1212010011"],"award-info":[{"award-number":["No. 2022B1212010011"]}]},{"name":"Science and Technology Projects in Guangzhou","award":["2024A04J4977"],"award-info":[{"award-number":["2024A04J4977"]}]},{"name":"the Talent Introduction Supporting Funds of Guangdong Provincial People's Hospital","award":["KY0120230009"],"award-info":[{"award-number":["KY0120230009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The unique biology of early-onset locally advanced rectal cancer (EOLARC) may drive distinct failure patterns, challenging current age-agnostic management. This multicenter retrospective study aimed to define these patterns compared to late-onset disease (LOLARC) and develop a tailored magnetic resonance imaging (MRI)-based risk score. We analyzed 1289 patients undergoing neoadjuvant chemoradiotherapy and surgery. After propensity score matching, EOLARC patients exhibited higher local recurrence rates (4.9% vs. 1.7%;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.03) despite similar pathological complete response (pCR) rates (25.5% vs. 21.2%;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.22). The novel mrTML score (incorporating tumor deposits, mesorectal fascia, and lateral lymph nodes) effectively predicted local recurrence (adjusted hazard ratio for score 3 vs. 0, 33.99). Notably, high pre-treatment risk persisted even among patients achieving pCR (HR 12.02;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.003), highlighting failure patterns uncaptured by pathological response. The mrTML score is a robust tool to identify patients at high risk for local recurrence, providing an evidence-based framework for risk-adapted therapy.\n                  <\/jats:p>","DOI":"10.1038\/s41698-025-01244-6","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:48:27Z","timestamp":1766580507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Higher local recurrence as the distinct failure pattern in early-onset rectal cancer: a tailored MRI score to guide therapy"],"prefix":"10.1038","volume":"10","author":[{"given":"Yunrui","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibo","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Er","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMra2200869","volume":"386","author":"FA Sinicrope","year":"2022","unstructured":"Sinicrope, F. A. Increasing incidence of early-onset colorectal cancer. N. Engl. J. Med. 386, 1547\u20131558 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1244_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H. & Boland, C. R. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol. Hepatol. 7, 262\u2013274 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1244_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-023-00432-7","volume":"9","author":"MCW Spaander","year":"2023","unstructured":"Spaander, M. C. W. et al. Young-onset colorectal cancer. Nat. Rev. Dis. Primer 9, 21 (2023).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"1244_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.gastro.2019.07.055","volume":"158","author":"EM Stoffel","year":"2020","unstructured":"Stoffel, E. M. & Murphy, C. C. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology 158, 341\u2013353 (2020).","journal-title":"Gastroenterology"},{"key":"1244_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/jamasurg.2014.1756","volume":"150","author":"CE Bailey","year":"2015","unstructured":"Bailey, C. E. et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 150, 17 (2015).","journal-title":"JAMA Surg."},{"key":"1244_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/cncr.29716","volume":"122","author":"ZM Abdelsattar","year":"2016","unstructured":"Abdelsattar, Z. M. et al. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer 122, 929\u2013934 (2016).","journal-title":"Cancer"},{"key":"1244_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/bjs.10318","volume":"104","author":"S Pucciarelli","year":"2017","unstructured":"Pucciarelli, S. et al. Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer. Br. J. Surg. 104, 138\u2013147 (2017).","journal-title":"Br. J. Surg."},{"key":"1244_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/JOP.19.00153","volume":"16","author":"YN You","year":"2020","unstructured":"You, Y. N., Lee, L. D., Deschner, B. W. & Shibata, D. Colorectal cancer in the adolescent and young adult population. JCO Oncol. Pract. 16, 19\u201327 (2020).","journal-title":"JCO Oncol. Pract."},{"key":"1244_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11605-014-2645-7","volume":"19","author":"CE Bailey","year":"2015","unstructured":"Bailey, C. E. et al. Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J. Gastrointest. Surg. 19, 180\u2013188 (2015).","journal-title":"J. Gastrointest. Surg."},{"key":"1244_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/jamasurg.2021.2380","volume":"156","author":"AM Zaborowski","year":"2021","unstructured":"REACCT Collaborative, Zaborowski, A. M. et al. Characteristics of early-onset vs late-onset colorectal cancer: a review. JAMA Surg. 156, 865 (2021).","journal-title":"JAMA Surg."},{"key":"1244_CR11","doi-asserted-by":"crossref","unstructured":"Tang, J. et al. Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study. Int. J. Surg. 110, 4559\u20134570 (2024).","DOI":"10.1097\/JS9.0000000000001584"},{"key":"1244_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.surg.2011.08.013","volume":"151","author":"P Jo","year":"2012","unstructured":"Jo, P. et al. CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer. Surgery 151, 564\u2013570 (2012).","journal-title":"Surgery"},{"key":"1244_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ijrobp.2014.11.013","volume":"91","author":"YJ Ha","year":"2015","unstructured":"Ha, Y. J. et al. Epigenetic regulation of KLHL34 predictive of pathologic response to preoperative chemoradiation therapy in rectal cancer patients. Int. J. Radiat. Oncol. 91, 650\u2013658 (2015).","journal-title":"Int. J. Radiat. Oncol."},{"key":"1244_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.6004\/jnccn.2024.0041","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson, A. B. et al. NCCN guidelines insights: rectal cancer, version 3.2024: featured updates to the NCCN guidelines. J. Natl. Compr. Cancer Netw. 22, 366\u2013375 (2024).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"1244_CR15","doi-asserted-by":"publisher","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones, R. et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 28, iv22\u2013iv40 (2017).","journal-title":"Ann. Oncol."},{"key":"1244_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/jamasurg.2014.3572","volume":"150","author":"PJ Kneuertz","year":"2015","unstructured":"Kneuertz, P. J. et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 150, 402\u2013409 (2015).","journal-title":"JAMA Surg."},{"key":"1244_CR17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41416-024-02652-4","volume":"130","author":"J Cai","year":"2024","unstructured":"Cai, J. et al. Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial. Br. J. Cancer 130, 1434\u20131440 (2024).","journal-title":"Br. J. Cancer"},{"key":"1244_CR18","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1002\/cncr.31527","volume":"124","author":"A Kolarich","year":"2018","unstructured":"Kolarich, A. et al. Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline\u2013directed treatment for stage II and III disease. Cancer 124, 3510\u20133519 (2018).","journal-title":"Cancer"},{"key":"1244_CR19","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232838","volume":"314","author":"S Nougaret","year":"2025","unstructured":"Nougaret, S. et al. MRI of the rectum: a decade into DISTANCE, moving to DISTANCED. Radiology 314, e232838 (2025).","journal-title":"Radiology"},{"key":"1244_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2022.101739","volume":"43","author":"MC Fernandes","year":"2022","unstructured":"Fernandes, M. C., Gollub, M. J. & Brown, G. The importance of MRI for rectal cancer evaluation. Surg. Oncol. 43, 101739 (2022).","journal-title":"Surg. Oncol."},{"key":"1244_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/SLA.0000000000004636","volume":"275","author":"F Rouleau Fournier","year":"2022","unstructured":"Rouleau Fournier, F. et al. Oncologic outcomes associated with MRI-detected extramural venous invasion (mrEMVI) in rectal cancer: a systematic review and meta-analysis. Ann. Surg. 275, 303\u2013314 (2022).","journal-title":"Ann. Surg."},{"key":"1244_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1200\/JCO.2012.45.3258","volume":"32","author":"FGM Taylor","year":"2014","unstructured":"Taylor, F. G. M. et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J. Clin. Oncol. 32, 34\u201343 (2014).","journal-title":"J. Clin. Oncol."},{"key":"1244_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SLA.0000000000004499","volume":"276","author":"AC Lord","year":"2022","unstructured":"Lord, A. C. et al. MRI-diagnosed tumor deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer. Ann. Surg. 276, 334\u2013344 (2022).","journal-title":"Ann. Surg."},{"key":"1244_CR24","doi-asserted-by":"publisher","first-page":"e192172","DOI":"10.1001\/jamasurg.2019.2172","volume":"154","author":"A Ogura","year":"2019","unstructured":"Ogura, A. et al. Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg. 154, e192172 (2019).","journal-title":"JAMA Surg."},{"key":"1244_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.111954","volume":"184","author":"T Hu","year":"2025","unstructured":"Hu, T. et al. Impact of MRI risk assessment on the survival benefits of neoadjuvant chemoradiotherapy in patients with stage II-III rectal cancer: a retrospective cohort study. Eur. J. Radiol. 184, 111954 (2025).","journal-title":"Eur. J. Radiol."},{"key":"1244_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1470-2045(22)00214-5","volume":"23","author":"AC Lord","year":"2022","unstructured":"Lord, A. C. et al. Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study. Lancet Oncol. 23, 793\u2013801 (2022).","journal-title":"Lancet Oncol."},{"key":"1244_CR27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41416-023-02384-x","volume":"129","author":"M Zhao","year":"2023","unstructured":"Zhao, M. et al. An MRI-based scoring system for pretreatment risk stratification in locally advanced rectal cancer. Br. J. Cancer 129, 1095\u20131104 (2023).","journal-title":"Br. J. Cancer"},{"key":"1244_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114044","volume":"204","author":"WH Zwart","year":"2024","unstructured":"Zwart, W. H. et al. Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial. Eur. J. Cancer 204, 114044 (2024).","journal-title":"Eur. J. Cancer"},{"key":"1244_CR29","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","volume":"11","author":"M Maas","year":"2010","unstructured":"Maas, M. et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 11, 835\u2013844 (2010).","journal-title":"Lancet Oncol."},{"key":"1244_CR30","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/jamaoncol.2017.5597","volume":"4","author":"F Dossa","year":"2018","unstructured":"Dossa, F. et al. Association between adjuvant chemotherapy and overall survival in patients with rectal cancer and pathological complete response after neoadjuvant chemotherapy and resection. JAMA Oncol. 4, 930 (2018).","journal-title":"JAMA Oncol."},{"key":"1244_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241229434","volume":"16","author":"B Liu","year":"2024","unstructured":"Liu, B. et al. Distinct clinical characteristics in stage III rectal cancer among different age groups and treatment outcomes after neoadjuvant chemoradiotherapy. Ther. Adv. Med. Oncol. 16, 17588359241229434 (2024).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"1244_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00719-2","volume":"8","author":"J Zhen","year":"2024","unstructured":"Zhen, J. et al. Development and validation of machine learning models for young-onset colorectal cancer risk stratification. npj Precis. Oncol. 8, 239 (2024).","journal-title":"npj Precis. Oncol."},{"key":"1244_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00384-024-04604-z","volume":"39","author":"SH Emile","year":"2024","unstructured":"Emile, S. H. et al. Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer. Int. J. Colorectal. Dis. 39, 43 (2024).","journal-title":"Int. J. Colorectal. Dis."},{"key":"1244_CR34","doi-asserted-by":"publisher","first-page":"592","DOI":"10.21037\/jgo-20-300","volume":"12","author":"R Habib","year":"2021","unstructured":"Habib, R. et al. Outcomes of young patients diagnosed with locally advanced rectal cancer. J. Gastrointest. Oncol. 12, 592\u2013601 (2021).","journal-title":"J. Gastrointest. Oncol."},{"key":"1244_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1219608","volume":"13","author":"D Zeng","year":"2023","unstructured":"Zeng, D. et al. Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis. Front. Oncol. 13, 1219608 (2023).","journal-title":"Front. Oncol."},{"key":"1244_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/bmj.38937.646400.55","volume":"333","author":"MERCURY Study Group","year":"2006","unstructured":"MERCURY Study Group Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333, 779 (2006).","journal-title":"BMJ"},{"key":"1244_CR37","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.2002.07.010","volume":"20","author":"ID Nagtegaal","year":"2002","unstructured":"Nagtegaal, I. D. et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J. Clin. Oncol. 20, 1729\u20131734 (2002).","journal-title":"J. Clin. Oncol."},{"key":"1244_CR38","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1002\/cam4.5120","volume":"12","author":"D Shen","year":"2023","unstructured":"Shen, D. et al. Clinical spectrum of rectal cancer identifies hallmarks of early-onset patients and next-generation treatment strategies. Cancer Med. 12, 3433\u20133441 (2023).","journal-title":"Cancer Med."},{"key":"1244_CR39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S1470-2045(25)00239-6","volume":"26","author":"J Li","year":"2025","unstructured":"Li, J. et al. Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study. Lancet Oncol. 26, 1055\u20131066 (2025).","journal-title":"Lancet Oncol."},{"key":"1244_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41571-024-00967-y","volume":"22","author":"K Pantel","year":"2025","unstructured":"Pantel, K. & Alix-Panabi\u00e8res, C. Minimal residual disease as a target for liquid biopsy in patients with solid tumours. Nat. Rev. Clin. Oncol. 22, 65\u201377 (2025).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1244_CR41","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","volume":"30","author":"Y Nakamura","year":"2024","unstructured":"Nakamura, Y. et al. ctDNA-based molecular residual disease and survival in resectable colorectal cancer. Nat. Med. 30, 3272\u20133283 (2024).","journal-title":"Nat. Med."},{"key":"1244_CR42","doi-asserted-by":"crossref","unstructured":"Sekhon Inderjit Singh, H. K., Lord, A., Pawa, N. & Brown, G. The prognostic impact of imaging detected tumor deposits in rectal cancer: a systematic review and meta-analysis. Ann. Surg. Oncol. 33, 199-209 (2026).","DOI":"10.1245\/s10434-025-18371-w"},{"key":"1244_CR43","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1200\/JCO.22.02166","volume":"41","author":"R Ruppert","year":"2023","unstructured":"Ruppert, R. et al. Risk-adapted neoadjuvant chemoradiotherapy in rectal cancer: final report of the OCUM study. J. Clin. 41, 4025\u20134034 (2023).","journal-title":"J. Clin."},{"key":"1244_CR44","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/j.clon.2022.12.006","volume":"35","author":"SP Bach","year":"2023","unstructured":"Bach, S. P. STAR-TREC: an international three-arm multicentre, partially randomised controlled trial incorporating an external pilot. Clin. Oncol. 35, e107\u2013e109 (2023).","journal-title":"Clin. Oncol."},{"key":"1244_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/codi.70059","volume":"27","author":"S Bedrikovetski","year":"2025","unstructured":"Bedrikovetski, S. et al. Total neoadjuvant therapy in early-onset rectal cancer: a multicentre prospective cohort study. Colorectal Dis. 27, e70059 (2025).","journal-title":"Colorectal Dis."},{"key":"1244_CR46","unstructured":"Audisio A. et al. Total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 11, 1045\u20131054 (2025)."},{"key":"1244_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","volume":"35","author":"T Conroy","year":"2024","unstructured":"Conroy, T. et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 35, 873\u2013881 (2024).","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"1244_CR48","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/jamaoncol.2020.2394","volume":"6","author":"M Diefenhardt","year":"2020","unstructured":"Diefenhardt, M. et al. Association of treatment adherence with oncologic outcomes for patients with rectal cancer: a post hoc analysis of the CAO\/ARO\/AIO-04 phase 3 randomized clinical trial. JAMA Oncol. 6, 1416 (2020).","journal-title":"JAMA Oncol."},{"key":"1244_CR49","doi-asserted-by":"publisher","first-page":"e2432927","DOI":"10.1001\/jamanetworkopen.2024.32927","volume":"7","author":"M Diefenhardt","year":"2024","unstructured":"Diefenhardt, M. et al. Persistent lymph node metastases after neoadjuvant chemoradiotherapy for rectal cancer. JAMA Netw. Open 7, e2432927 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1244_CR50","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1158\/1078-0432.CCR-15-0939","volume":"22","author":"P Yan","year":"2016","unstructured":"Yan, P. et al. Reduced expression of SMAD4 is associated with poor survival in colon cancer. Clin Cancer Res. 22, 3037\u20133047 (2016).","journal-title":"Clin Cancer Res."},{"key":"1244_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/jclinpath-2014-202660","volume":"68","author":"MM Kozak","year":"2015","unstructured":"Kozak, M. M. et al. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer. J. Clin. Pathol. 68, 341\u2013345 (2015).","journal-title":"J. Clin. Pathol."},{"key":"1244_CR52","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/gutjnl-2014-309086","volume":"64","author":"EH Schreuders","year":"2015","unstructured":"Schreuders, E. H. et al. Colorectal cancer screening: a global overview of existing programmes. Gut 64, 1637\u20131649 (2015).","journal-title":"Gut"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01244-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01244-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:25:56Z","timestamp":1769527556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-01244-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-01244-6","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}